selected publications
-
Pain, Analgesic Use, and Patient Satisfaction With Spinal Versus General Anesthesia for Hip Fracture Surgery : A Randomized Clinical Trial.
Annals of internal medicine.
2022
Academic Article
GET IT
Times cited: 1 -
Protective ventilation with high versus low positive end-expiratory pressure during one-lung ventilation for thoracic surgery (PROTHOR): study protocol for a randomized controlled trial.
Trials.
2019
Academic Article
GET IT
Times cited: 37 -
Preclinical Pharmacology in the Rhesus Monkey of CW 1759-50, a New Ultra-short Acting Nondepolarizing Neuromuscular Blocking Agent, Degraded and Antagonized by L-Cysteine.
Anesthesiology.
2018
Academic Article
GET IT
Times cited: 1 -
New trends in interventional pulmonology.
Current opinion in anaesthesiology.
2017
Information Resource
GET IT
Times cited: 3 -
Dose-response and Cardiopulmonary Side Effects of the Novel Neuromuscular-blocking Drug CW002 in Man.
Anesthesiology.
2016
Academic Article
GET IT
Times cited: 9 - Preclinical Pharmacology of CW002: A Nondepolarizing Neuromuscular Blocking Drug of Intermediate Duration, Degraded and Antagonized by l-cysteine-Additional Studies of Safety and Efficacy in the Anesthetized Rhesus Monkey and Cat. Anesthesiology. 2016 Academic Article GET IT
-
Paramyxovirus receptor-binding molecules: engagement of one site on the hemagglutinin-neuraminidase protein modulates activity at the second site.
Journal of virology.
2006
Academic Article
GET IT
Times cited: 57 -
Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein.
Journal of virology.
2005
Academic Article
GET IT
Times cited: 57 -
Inhibition of parainfluenza virus type 3 and Newcastle disease virus hemagglutinin-neuraminidase receptor binding: effect of receptor avidity and steric hindrance at the inhibitor binding sites.
Journal of virology.
2004
Academic Article
GET IT
Times cited: 55 -
Triggering of human parainfluenza virus 3 fusion protein (F) by the hemagglutinin-neuraminidase (HN) protein: an HN mutation diminishes the rate of F activation and fusion.
Journal of virology.
2003
Academic Article
GET IT
Times cited: 78 -
Mutations in human parainfluenza virus type 3 hemagglutinin-neuraminidase causing increased receptor binding activity and resistance to the transition state sialic acid analog 4-GU-DANA (Zanamivir).
Journal of virology.
2003
Academic Article
GET IT
Times cited: 45 -
A single amino acid alteration in the human parainfluenza virus type 3 hemagglutinin-neuraminidase glycoprotein confers resistance to the inhibitory effects of zanamivir on receptor binding and neuraminidase activity.
Journal of virology.
2001
Academic Article
GET IT
Times cited: 22